-- Dabur, Nestle India, Dr. Reddy's, Marico, Tata Power: India Equity Preview
-- Ruth David
-- 2010-07-08T01:30:00Z
-- http://www.bloomberg.com/news/2010-07-08/dabur-nestle-india-dr-reddy-s-marico-tata-power-india-equity-preview.html

          
          
             The following companies may have
 unusual  price changes in India  trading . Stock symbols are in
parentheses and share prices are as of the  last close .  
 The Bombay Stock Exchange Sensitive Index, or  Sensex , fell
0.8 percent to 17,471.03. The S&P CNX  Nifty  Index on the
National Stock Exchange declined 0.9 percent to 5,241.10. The
 BSE 200 Index  decreased 0.7 percent to 2,227.34.  
 Dabur India Ltd.  (DABUR IN): The maker of products
including shampoos and beverages was downgraded to “hold” from
“buy” at Antique Stock Broking by equity analyst  Abhijeet Kundu . The target price is 219 rupees. The stock rose 1.1
percent to 208 rupees.  
 Dr Reddys Laboratories Ltd.  (DRRD IN): India’s second-
largest drugmaker by revenue was rated new “hold” at Ambit
Capital by equity analyst Anshuman Gupta. The 12-month target
price is 1,514 rupees. The shares fell 1.1 percent to 1,454.25
rupees.  
 IndusInd Bank Ltd.  (IIB IN) was rated new “buy” at UBS AG by
equity analyst Ajitesh Nair. The target price is 250 rupees. The
stock rose 0.1 percent to 210.35 rupees.  
 Marico Ltd.  (MRCO IN): The maker of hair-grooming products
was raised to “buy” from “hold” at Antique Stock Broking by
Kundu. The target price is 138 rupees. The shares rose 4 percent
to 130.25 rupees.  
 Nestle India Ltd.  (NEST IN): The unit of the world’s
biggest foodmaker was raised to “buy” from “hold” at Antique
Stock Broking by Kundu. The target price is 3,418 rupees. The
stock fell 1.9 percent to 3,033.95 rupees.  
 Rural Electrification Corp.  (RECL IN): The Indian central
bank halted further purchases of shares by foreign investors in
Rural Electrification, which finances generation projects in the
country, as they approached their limit, the central bank said
in a statement. Overseas funds need to get approval from the
regulator, it said. The shares fell 0.8 percent to 296.5 rupees.  
 Sun Pharmaceutical Industries Ltd.  (SUNP IN): India’s
largest drugmaker by market value was rated new “buy” at Ambit
Capital by analyst Gupta. The 12-month target price is 2,067
rupees. The shares fell 1.6 percent to 1,771.4 rupees.  
 Tata Power Co.  (TPWR IN): India’s biggest non-state
generator hired Citigroup Inc. to help it raise 3.5 billion
rupees ($74 million) from bond sales, a person familiar with the
matter said. The company also said it plans to set up solar
facilities with capacity of 300 megawatts by 2013. The shares
fell 0.7 percent to 1,304.95 rupees.  
 To contact the reporters on this story:
 Ruth David  in Mumbai at 
 rdavid9@bloomberg.net   
          
          


  


        